The problem of developing a detoxified Flexner dysentery antigen for use in the armed forces during the recent war (Barnes, Dewey, Henry, and Lupfer, 1947; required a test by which the results of a given chemical or physical manipulation of the antigen could be evaluated with respect to both toxicity and protection. It was necessary to do this with such precision and definition of standards that progress in detoxification could be followed quantitatively. This meant that altered antigens had to be compared with crude vaccines in terms of a smaller or a larger number of toxic units that were capable of yielding an identical degree of protection against infection. To accomplish these ends, it was necessary to adapt several methods to one test and to make this applicable to the dysentery organism. No one test or combination of tests fulfilling these needs was found available or easily adaptable.
The problem of developing a detoxified Flexner dysentery antigen for use in the armed forces during the recent war (Barnes, Dewey, Henry, and Lupfer, 1947;  required a test by which the results of a given chemical or physical manipulation of the antigen could be evaluated with respect to both toxicity and protection. It was necessary to do this with such precision and definition of standards that progress in detoxification could be followed quantitatively. This meant that altered antigens had to be compared with crude vaccines in terms of a smaller or a larger number of toxic units that were capable of yielding an identical degree of protection against infection. To accomplish these ends, it was necessary to adapt several methods to one test and to make this applicable to the dysentery organism. No one test or combination of tests fulfilling these needs was found available or easily adaptable.
In the first place, a representative measure of toxicity of successive dilutions of antigen had to be worked out for the dysentery organism. Although weight loss has been used for many tests of physiological effect, it has not been shown whether it is a generally reliable index of toxicity and it had not been clearly applied to Flexner dysentery toxicity in the mouse as a well-defined test. This convenient property of weight loss was chosen because it was found to be proportional to the logarithm of the dose of antigen given (see below), and in all tests with either unaltered or detoxified material, no discrepancy between weight loss and observed symptoms in mice could be noted.
Secondly, it was important to develop corresponding precision in a protection test rather than by immune body titration because high protectivity against infection was the chief and practical aim; a nuimber of steps had to be taken to achieve adequate precision in this part of the test. For purposes of exploration, the mouse was employed rather than humans, although final results have been checked in the latter (Barnes, Dewey, Henry, and Lupfer, 1947) . The protective power of an antigen is titrated a week after its administration by injecting each of the same mice with a carefully standardized dose of live virulent organisms.
Thirdly, it was felt necessary to use the same mice for assaying both toxicity and protection of a given sample; by choice of the tests for weight loss and protection and by adjustment of dosages it was found possible to accomplish this, although not without considerable difficulty and many trials. The advantages of using the same mice are twofold: (1) unknown secondary effects upon protection from various degrees of toxicity damage to the organism receiving the vaccine are of vital importance and can only be taken into account by using the same mice for the two parts of the test; (2) the errors involved in biological tests are greatly decreased if one set of animals is used to obtain a final value.
A batch of 50 white mice, weighing 15 to 18 g each, are caged in groups of 5 and kept at a constant temperature of 25 C. After 2 days they are weighed to 0.1 g in groups of 5, and each mouse is immediately injected intraperitoneally with 0.5 ml of the vaccine to be tested. The vaccine is diluted so that each suc- Group weight change in -6.1 -5.1 -0. succeeding points along the logarithmic co-ordinate, we find we have plotted values of log (1 + n), in which n is implicit in the expression:
Here C. and C. represent concentration at any dilution n and at n equal to zero, respectively, n being a whole number in the series 0,1,2,3,4, --defining the number of 2-fold dilutions made at any point. The dilution factor, x, in all cases described in this paper is equal to 2. An improvement on the straight line is to fit to the points visually a curved line, the ends of which are made to approach parallelism to the y axis. This alteration at either end is in keeping with the presence of a physiological limit on weight gain and weight loss in any 24-hour period. If desired, some other end point than zero weight change may be chosen; in fact, we have found that the point of 2-g weight loss for 5 mice is more reliable in comparing some fractions with one another.
Besides graphical methods, another, which permits statistical analysis of the precision in a single test, is to weigh the mice individually. From the series of records (table 1) one can compute a 50 per cent end point that is the best available estimate of the amount of antigen required to produce a loss of weight in one-half of all mice (e.g., Reed and Muench, 1938; Bliss, 1938) .
Seven days after the injection of the vaccine preparation, each mouse is given 0.5 ml of a 3 per cent suspension of mucin containing I volume of a 21-hour-old culture of virulent Shigella parady8enteriae organisms (about 70 million organisms per mouse). This is 10,000 to 100,000 MLD. To avoid the injection of particles, the mucin suspension is passed through a Waring blender and, after sterilizing, through a hand homogenizer. It is then centrifuged, and to the decanted, neutralized supernatant, which is surrounded by an ice bath and mechanically stirred, the bacteria are added. Aliquots of this suspension are removed by an automatic syringe and injected. Sixteen to 18 hours later the number of sick and dead mice in each cage is recorded. Those mice are counted as sick whose eyes are partially or completely closed by exudate or edema. This end point was chosen because by trial the results were more dependable than by the survival criterion alone. The latter may be subject to many subtle, unknown influences in addition to those involved in the production of a given intensity of diseased state. Exudate and eye closing in this Flexner infection in mice was an objective, unequivocal finding and occurred almost invariably when mice were otherwise distinctly ill. The end point is determined similarly to an LDN end point (Reed and Muench, 1938) , as shown in table 1. Also it may be estimated by graphing the results, for which a simple sigmoid curve is given in figure 2 .
Each antigen dilution may be recorded as the number of bacteria in millions, or as the number of mg of dried antigen, or as the number of mg of nitrogen to which it corresponds. The level of toxicity of a given antigen divided by the level of protection is the ratio of toxicity to antigenicity for that fraction. This ratio may be compared to that of other fractions titrated simultaneously with other mice, and it is then possible to say that one antigen is so many times more or less effective than another as an immunizing agent. Of two antigens with the ratios expressed as above, that with the higher ratio is the more favorable, i.e., more antigenic for a given degree of toxicity. Finally, a vaccine preparation titrated at one time may be compared with that assayed at another if a standard vaccine is also titrated to provide a point of reference. For this purpose a standard reference vaccine, consisting of killed organisms suspended in saline and dried from the frozen state, was prepared in large amounts.
The test also may be used as a quantitative measure of the proportion of toxicity or of protective power in a chemically prepared fraction of bacteria relative to that present in the whole organism. This is done by comparing the titration end point of a given fraction, in terms of numbers of grams of unaltered bacteria giving that same end point, with the end point obtained by titration of the whole bacteria. Thus, after a given chemical step yielding two products, the fraction of effective antigen in each may be estimated.
The precision of the test can be improved by the use of 10 mice per dilution instead of 5. The reproducibility of the toxicity-protection ratio of a given preparation in a single test using 5-mouse groups is shown in toxifying it is given in dosage, At, so chosen that the untreated, undetoxified material in the same dosage gives a weight loss in 10 mice of about 20 to 22 g in 24 hours. In order to provide a common unit basis for each of the 11 preparations, the point of 2-g weight loss in 5 mice was arbitrarily assigned the same dosage value in each case, and the other points of the y axis were adjusted accordingly so as to relate the dilutions by a factor of 2. As this arbitrary level could be set at any figure, it was so chosen in relation to the unitage for the protection curve (q.v.) that the average toxicity-protection ratio from 8 different measurements of unaltered antigen at the 100-ug level was equal to one (see equations in text). The dosage so chosen was 15.4 pg at the level of 2-g weight loss in 5 mice. The standard deviations of the dosage units for each point of the graph are (in order from the highest dosage): 82.3, 70.2, 32.9, 20.5, 13.5, 5.50, 1.08, zero, 1.11 In order to provide a common unit basis for each of the 8 preparations, the 50 per cent end point was arbitrarily assigned the same dosage value in each case and the other points on the y axis were adjusted accordingly so as to relate dilutions by a factor of 2. This value was set at 64 because of the convenience of this number for expressing related concentrations by a factor of 2. The standard deviations of the dosage units for each point on the graph are (in order from the highest dosage): 107.3, 28.0, 6.63, 4.72, zero, 4.32, 4.59, 5.78, 3.52. on unaltered antigen (see figure 3 ) the weight loss incurred by the mice for a given preparation or standard is read in terms of equivalent dose, St., St., respectively, of unaltered reference vaccine (see legend, figure 3) .
(e) Protection tests are run simultaneously on all batches the next week, in the manner previously described, and from a standard graph, similarly pre- (Usually these refer to the same material that was given the week before to test toxicity, but the protection part of the procedure may be tested separately at some different dosage level if desired.)
It can be shown readily that the percentage of decrease in toxicity, D, of a given preparation of antigen, A, is expressed by the following: D = 100-(lOOSta X WS) (Ap X spt) However, in all of our tests, the doses given to estimate toxicity and protection are the same for any given preparation, A'; therefore A = A' and W. = Wt.
It follows that: D = 100 -(100 S6ae) (SDW)
Since the ratio SPW was not considered significantly altered from one (see legend, sttD figure 3), the expression usually could be used in a shortened form as follows:
-(100 Sta') ( Sa ) Thus D expresses complete loss of toxicity as 100 per cent detoxification; or, if the toxicity of a given dose of treated antigen were reduced to that obtained from X dose of unaltered material, D would equal 75 per cent.
The error in terms of standard deviations for the reference curves is given in the legends to figures 3 and 4. The reproducibility of the 20-mouse screening test is indicated in table 4, in which the results of successive tests over many weeks show a consistent loss of net toxicity for all but the last fraction, which was not appreciably changed.
SUMMARY
A method for measurement of changes in toxicity relative to antigenicity of a vaccine is described. The test uses a single series of mice for the assay of both quantities, toxicity being estimated by weight loss, and protection, after a week's interval, by resistance to a challenging dose of live organisms.
